Literature DB >> 2590046

The relationship between nuclear DNA content in salivary gland tumors and prognosis. Comparison of mucoepidermoid tumors and acinic cell tumors.

K Hamper1, J Caselitz, H Arps, U Askensten, G Auer, G Seifert.   

Abstract

Differences in prognosis between salivary gland mucoepidermoid tumors and acinic cell tumors were compared by means of conventional histopathological grading and nuclear DNA content which was assessed cytochemically by a scanning cytophotometric procedure. The mucoepidermoid tumors were found to show a stronger correlation between histopathological grading and prognosis than did the acinic cell tumors. By using DNA quantification, valuable additional information could be obtained for predicting the behavior of the mucoepidermoid tumors, whereas there was no correlation between DNA content and prognosis for the acinic cell tumors. Regarding the relatively "benign" clinical course of most mucoepidermoid tumors, the term "tumor"--as proposed by the World Health Organization's classification--seems appropriate. In contrast, the more severe clinical courses of the acinic cell tumors justify the use of the term "carcinoma" instead.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590046     DOI: 10.1007/bf00463587

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  26 in total

1.  Mucoepidermoid tumors of major and minor salivary glands. Clinical features, histology, variations, natural history, and results of treatment for 144 cases.

Authors:  S N BHASKAR; J L BERNIER
Journal:  Cancer       Date:  1962 Jul-Aug       Impact factor: 6.860

2.  Nuclear DNA in salivary gland tumors. I. Warthin tumors, benign mixed tumors, and mucoepidermoid carcinomas.

Authors:  I Kino; R M Richart; R Lattes
Journal:  Arch Pathol       Date:  1973-04

3.  Nuclear DNA in salivary gland tumors. II. Adenocystic carcinomas.

Authors:  I Kino; R M Richart; R Lattes
Journal:  Arch Pathol       Date:  1973-05

4.  Malignancy of acinic cell tumours elucidated by microspectrophotometric DNA analysis.

Authors:  C M Eneroth; C Silfverswärd; A Zetterbeg
Journal:  Acta Otolaryngol       Date:  1974 Jan-Feb       Impact factor: 1.494

5.  Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment.

Authors:  W V Healey; K H Perzin; L Smith
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

6.  The relationship between the nuclear DNA content in smears of aspirates and the prognosis of mucoepidermoid carcinoma.

Authors:  C M Eneroth; A Zetterberg
Journal:  Acta Otolaryngol       Date:  1975 Nov-Dec       Impact factor: 1.494

7.  [Borderline tumors of the ovary. New aspects on morphologic prognosis determination].

Authors:  M Dietel; R Bodecker; H Arps; J Bahnsen; F Hölzel
Journal:  Geburtshilfe Frauenheilkd       Date:  1985-04       Impact factor: 2.915

8.  Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1984-06       Impact factor: 2.493

9.  Acinic cell carcinoma: a clinicopathologic study of thirty-five cases.

Authors:  J G Batsakis; E K Chinn; T A Weimert; W P Work; C J Krause
Journal:  J Laryngol Otol       Date:  1979-04       Impact factor: 1.469

10.  Cytochemical changes in the nucleus during tumour development.

Authors:  T Caspersson; G Auer; A Fallenius; J Kudynowski
Journal:  Histochem J       Date:  1983-04
View more
  2 in total

Review 1.  Salivary acinic cell carcinoma: reappraisal and update.

Authors:  V Vander Poorten; A Triantafyllou; L D R Thompson; J Bishop; E Hauben; J Hunt; A Skalova; G Stenman; R P Takes; D R Gnepp; H Hellquist; B Wenig; D Bell; A Rinaldo; A Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

2.  Prognostic significance of DNA ploidy in mucoepidermoid carcinoma.

Authors:  P Gemryd; P G Lundquist; M Tytor; H B Hellquist; B Nordenskjöld
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.